PreviousNext
  • Subscribe to HTA Quarterly

    Get at-a-glance updates on important HTA decisions. Each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs.

    Read More
  • Subscribe to Health Policy Weekly

    Recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry.

    Read More

1 of 0 Items

  • White Paper: Commercializing Cell and Gene Therapies

    Every moment counts when working with life-saving and industry changing treatments. Our white paper, Commercializing Cell and Gene Therapies, offers actionable insights for those ready to shape this new landscape. Authored by AmerisourceBergen’s multi-disciplinary and market-leading experts, readers will learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain. More

  • Issue Brief: Payer Perceptions and Utilization of ICER Value Assessment Framework

    ICER was established as an independent, nonprofit organization that evaluates the value and affordability of drugs and other therapies. While ICER has gained both praise and criticism, limited evidence has been gathered to evaluate payer perceptions and utilization of the ICER framework. Complete the form to learn about our survey findings that illustrate the impact of the ICER framework on payer decision making. More

  • Xcenda Conducts Unique Research on Air Medical Services Costs

    The Association of Air Medical Services (AAMS) commissioned Xcenda, part of AmerisourceBergen, to conduct independent research on the costs associated with providing emergent air medical transports. More

  • When the Outcome of an Appraisal Is Not NICE: An Overview of the Appeal Process

    The National Institute for Health and Care Excellence (NICE) has gained notoriety for its evidence-based appraisal guidance on health technologies which include medicines, medical devices, diagnostic techniques, surgical procedures, and health promotion activities. We examine the procedures for technology appraisal by NICE and we explore the appeals process when a decision is challenged. More

  • Try Out the HTA Decision Map

    Xcenda's Decision Map makes it easy to stay informed on key HTA decisions from Australia, Canada, France, Germany, and the United Kingdom. More

  • HTA Quarterly Archive: Insights to Bridge Science and Policy

    Find articles from current and past issues of the HTA Quarterly, Xcenda's e-newsletter written specifically by and for health economics and market access professionals. More

  • Health Policy Weekly Archive

    Miss a recent issue? Get up to date with the latest regulatory and legislative happenings and news that impact stakeholders in the healthcare industry. More

Explore More Insights

We invite you to explore our library of articles, webcasts, white papers, and more.